Sinziana Stanescu

Dr. Sinziana Stanescu

Ramon y Cajal University Hospital, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
ABAmaya Bélanger-Quintana
Amaya Bélanger-Quintana
FAFrancisco Arrieta
Francisco Arrieta
DBDelia Barrio-Carreras
Delia Barrio-Carreras
AMAna Bergua Martínez
Ana Bergua Martínez
EVElvira Cañedo Villarroya
Elvira Cañedo Villarroya
MCMercedes Martínez-Pardo Casanova
Mercedes Martínez-Pardo Casanova
Hyperammonaemia is a metabolic derangement that may cause severe neurological damage and even death due to cerebral oedema, further complicating the prognosis of its triggering disease. In small children it is a rare condition usually associated to inborn errors of the metabolism. As age rises, and especially in adults, it may be precipitated by heterogeneous causes such as liver disease, drugs, urinary infections, shock, or dehydration. In older patients, it is often overlooked, or its danger minimized. This protocol was drafted to provide an outline of the clinical measures required to normalise ammonia levels in patients of all ages, aiming to assist clinicians with no previous experience in its treatment. It is an updated protocol developed by a panel of experts after a review of recent publications. We point out the importance of frequent monitoring to assess the response to treatment, the nutritional measures that ensure not only protein restriction but adequate caloric intake and the need to avoid delays in the use of specific pharmacological therapies and, especially, extrarenal clearance measures. In this regard, we propose initiating haemodialysis when ammonia levels are >200–350 µmol/L in children up to 18 months of age and >150–200 µmol/L after that age.

1 November 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IBIrene Bravo
Irene Bravo
RNRosa Navarrete
Rosa Navarrete
AVAna Isabel Vega
Ana Isabel Vega
PRPedro Ruiz-Sala
Pedro Ruiz-Sala
MSMaría Teresa García Silva
María Teresa García Silva
PPPilar Rodríguez Pombo
Pilar Rodríguez Pombo
Congenital lactic acidosis (CLA) is a rare condition in most instances due to a range of inborn errors of metabolism that result in defective mitochondrial function. Even though the implementation of next generation sequencing has been rapid, the diagnosis rate for this highly heterogeneous allelic condition remains low. The present work reports our group’s experience of using a clinical/biochemical analysis system in conjunction with genetic findings that facilitates the taking of timely clinical decisions with minimum need for invasive procedures. The system’s workflow combines different metabolomics datasets and phenotypic information with the results of clinical exome sequencing and/or RNA analysis. The system’s use detected genetic variants in 64% of a cohort of 39 CLA-patients; these variants, 14 of which were novel, were found in 19 different nuclear and two mitochondrial genes. For patients with variants of unknown significance, the genetic analysis was combined with functional genetic and/or bioenergetics analyses in an attempt to detect pathogenicity. Our results warranted subsequent testing of antisense therapy to rescue the abnormal splicing in cultures of fibroblasts from a patient with a defective GFM1 gene. The discussed system facilitates the diagnosis of CLA by avoiding the need to use invasive techniques and increase our knowledge of the causes of this condition.

30 January 2022 in Amino Acids
Verified
Journal Article
Open access
PDF file
SSSinziana Stanescu
Sinziana Stanescu
ABAmaya Bélanger-Quintana
Amaya Bélanger-Quintana
BFBorja Manuel Fernandez-Felix
Borja Manuel Fernandez-Felix
PRPedro Ruiz-Sala
Pedro Ruiz-Sala
MVMercedes del Valle
Mercedes del Valle
MMMercedes Martinez-Pardo
Mercedes Martinez-Pardo
Background: Propionic acidemia is an inborn error of metabolism caused by a deficiency in the mitochondrial enzyme propionyl-CoA carboxylase that converts the propionyl CoA to methyl malonyl CoA. This leads to profound changes in distinct metabolic pathways, including the urea cycle, with consequences in ammonia detoxification. The implication of the tricarboxylic acid cycle is less well known, but its repercussions could explain both some of the acute and long-term symptoms of this disease. Materials and methods: The present observational study investigates the amino acid profiles of patients with propionic acidemia being monitored at the Hospital Ramón y Cajal (Madrid, Spain), between January 2015 and September 2017, comparing periods of metabolic stability with those of decompensation with ketosis and/or hyperammonemia. Results: The concentrations of 19 amino acids were determined in 188 samples provided by 10 patients. We identified 40 metabolic decompensation episodes (22 only with ketosis and 18 with hyperammonemia). Plasma glutamine and alanine levels were reduced during these metabolic crises, probably indicating deficiency of anaplerosis (p < 0.001 for both alanine and glutamine). Hypocitrulllinemia and hypoprolinemia were also detected during hyperammonemia (p < 0.001 and 0.03, respectively). Conclusions: The amino acid profile detected during decompensation episodes suggests deficient anaplerosis from propionyl-CoA and its precursors, with implications in other metabolic pathways like synthesis of urea cycle amino acids and ammonia detoxification.

18 May 2021 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
SSSinziana Stanescu
Sinziana Stanescu
ABAmaya Bélanger-Quintana
Amaya Bélanger-Quintana
BFBorja Manuel Fernandez-Felix
Borja Manuel Fernandez-Felix
FAFrancisco Arrieta
Francisco Arrieta
VQVictor Quintero
Victor Quintero
MMMercedes Martínez-Pardo
Mercedes Martínez-Pardo
Background: Propionic acidemia (PA), an inborn error of metabolism, is caused by a deficiency in propionyl-CoA carboxylase. Patients have to follow a diet restricted in the propiogenic amino acids isoleucine (Ile), valine (Val), methionine (Met) and threonine (Thr); proper adherence can prevent and treat acute decompensation and increase life expectancy. However, chronic complications occur in several organs even though metabolic control may be largely maintained. Bone marrow aplasia and anemia are among the more common. Materials and methods: In this retrospective study, data for patients with PA being monitored at the Hospital Ramón y Cajal (Madrid, Spain) (n = 10) in the past 10 years were examined to statistically detect relationships between persistent severe anemia outside of metabolic decompensation episodes and dietary practices such as natural protein intake and medical food consumption (special mixture of precursor-free amino acids) along with plasma levels of branched-chain amino acids (BCAA). High ferritin levels were deemed to indicate that a patient had received repeated transfusions for persistent anemia since data on hemoglobin levels at the moment of transfusion were not always passed on by the attending centers. Results: Three patients had severe, persistent anemia that required repeated blood transfusions. Higher medical food consumption and plasma Leu levels were associated with iron overload. Notably, natural protein intake and plasma Val were negatively correlated with ferritin levels. We also observed an inverse relationship between plasma Val/Leu and Ile/Leu ratios and ferritin. Conclusion: The present results suggest that severe anemia in patients with PA might be associated with low natural protein intake and BCAA imbalance.

5 March 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
MMMaria del Mar Meijon-Ortigueira
Maria del Mar Meijon-Ortigueira
ISIsabel Solares
Isabel Solares
CMCecilia Muñoz-Delgado
Cecilia Muñoz-Delgado
SSSinziana Stanescu
Sinziana Stanescu
MMMarta Morado
Marta Morado
JVJesús Villarrubia-Espinosa
Jesús Villarrubia-Espinosa
Gaucher disease is an inherited disorder in which there is a deficiency of the enzyme glucocerebrosidase, which leads to the accumulation of glucosylceramide. Although much scientific evidence is now available, there is still limited data on the impact on the different life stages of women with this disease. Among other alterations, a delay in menarche has been described, although it has not been related to fertility problems. Menorrhagia is relatively frequent, being related to the presence of thrombocytopenia, thrombocytopathies or coagulation disorders. On the other hand, pregnancy planning is an increasingly frequent concern. All patients should undergo genetic counseling, and it is important to monitor the appearance or worsening of organomegaly, bone and hematologic abnormalities to establish clinical and therapeutic recommendations. Management during the puerperium will depend on the evolution of gestation, and, during the lactation period, the potential appearance of bone complications should be assessed. An early onset of menopause, compared to the general population, has also been described, which may accelerate the development of osteopenia. Finally, although the usual screening protocols for neoplasms are currently being performed, it is recommended to watch for early signs of liver or renal neoplasms when examining the results of imaging tests performed during evaluations for this disease.

21 June 2022 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
SSSinziana Stanescu
Sinziana Stanescu
IBIrene Bravo
Irene Bravo
ABAmaya Bélanger-Quintana
Amaya Bélanger-Quintana
BPBelen Perez
Belen Perez
MMMontserrat Medina-Diaz
Montserrat Medina-Diaz
PPPilar Rodríguez Pombo
Pilar Rodríguez Pombo
Background: Monocarboxylate transporter 1 (MCT1) deficiency has recently been described as a rare cause of recurrent ketosis, the result of impaired ketone utilization in extrahepatic tissues. To date, only six patients with this condition have been identified, and clinical and biochemical details remain incomplete. Results: The present work reports a patient suffering from severe, recurrent episodes of metabolic acidosis and psychomotor delay, showing a pathogenic loss-of-function variation c.747_750del in homozygosity in SLC16A1 (which codes for MCT1). Persistent ketotic and lactic acidosis was accompanied by an abnormal excretion of organic acids related to redox balance disturbances. Together with an altered bioenergetic profile detected in patient-derived fibroblasts, this suggests possible mitochondrial dysfunction. Brain MRI revealed extensive, diffuse bilateral, symmetric signal alterations for the subcortical white matter and basal ganglia, together with corpus callosum agenesia. Conclusions: These findings suggest that the clinical spectrum of MCT1 deficiency not only involves recurrent atacks of ketoacidosis, but may also cause lactic acidosis and neuromotor delay with a distinctive neuroimaging pattern including agenesis of corpus callosum and other brain signal alterations.